TALCEPTRX Trademark

Trademark Overview

On Monday, September 28, 2015, a trademark application was filed for TALCEPTRX with the United States Patent and Trademark Office. The USPTO has given the TALCEPTRX trademark a serial number of 86770397. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 16, 2025. This trademark is owned by Peregrine Pharmaceuticals, Inc.. The TALCEPTRX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer, infectious diseases and diseases and disorders in which phosphatidylserine (PS) is a marker

General Information

Serial Number86770397
Word MarkTALCEPTRX
Filing DateMonday, September 28, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 16, 2025
Registration Number5601640
Registration DateTuesday, November 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer, infectious diseases and diseases and disorders in which phosphatidylserine (PS) is a marker

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 16, 2025
Primary Code005
First Use Anywhere DateThursday, September 27, 2018
First Use In Commerce DateThursday, September 27, 2018

Trademark Owner History

Party NameONCXERNA THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451
Party NameONCOLOGIE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameONCOLOGIE, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NamePeregrine Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTustin, CA 92780
Party NamePeregrine Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTustin, CA 92780

Trademark Events

Event DateEvent Description
Wednesday, January 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 1, 2015NEW APPLICATION ENTERED
Friday, October 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 2, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 16, 2016ASSIGNED TO EXAMINER
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 20, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 20, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2016SOU TEAS EXTENSION RECEIVED
Friday, September 23, 2016SOU EXTENSION 1 FILED
Friday, September 23, 2016SOU EXTENSION 1 GRANTED
Tuesday, September 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 24, 2017SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2017SOU EXTENSION 2 FILED
Friday, March 24, 2017SOU EXTENSION 2 GRANTED
Thursday, October 5, 2017SOU TEAS EXTENSION RECEIVED
Thursday, October 5, 2017SOU EXTENSION 3 FILED
Thursday, October 5, 2017SOU EXTENSION 3 GRANTED
Saturday, October 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 10, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 10, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 23, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018SOU EXTENSION 4 GRANTED
Monday, April 23, 2018SOU EXTENSION 4 FILED
Wednesday, April 25, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 28, 2018TEAS STATEMENT OF USE RECEIVED
Friday, September 28, 2018SOU TEAS EXTENSION RECEIVED
Friday, September 28, 2018SOU EXTENSION 5 FILED
Thursday, May 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 13, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 2, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 4, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 5, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 23, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 28, 2018USE AMENDMENT FILED
Tuesday, October 2, 2018SOU EXTENSION 5 GRANTED
Monday, March 23, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 23, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 15, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 23, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 23, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 24, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 15, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 16, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

talceptrx diseases disorders which phosphatidylserine marker infectious cancer namely preparations antibodies